Bioinformatic Analysis Reveals Central Role for Tumor-Infiltrating Immune Cells in Uveal Melanoma Progression

被引:9
|
作者
Lachota, Mieszko [1 ]
Lennikov, Anton [2 ]
Malmberg, Karl-Johan [3 ,4 ]
Zagozdzon, Radoslaw [5 ,6 ]
机构
[1] Med Univ Warsaw, Doctoral Sch, Dept Clin Immunol, PL-02006 Warsaw, Poland
[2] Harvard Med Sch, Dept Ophthalmol, Schepens Eye Res Inst Massachusetts Eye & Ear, Boston, MA 02115 USA
[3] Oslo Univ Hosp, Inst Canc Res, Dept Canc Immunol, N-0310 Oslo, Norway
[4] Karolinska Inst, Karolinska Univ Hosp, Dept Med Huddinge, Ctr Infect Med, S-14186 Stockholm, Sweden
[5] Med Univ Warsaw, Dept Clin Immunol, PL-02006 Warsaw, Poland
[6] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Regenerat Med, PL-02781 Warsaw, Poland
基金
瑞典研究理事会;
关键词
ANTIGEN EXPRESSION; HLA EXPRESSION; TGF-BETA; T-CELLS; LYMPHOCYTES; ANGIOGENESIS; CANCER; MATRIX-METALLOPROTEINASE-9; CLASSIFICATION; INCREASES;
D O I
10.1155/2021/9920234
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tumor-infiltrating immune cells are capable of effective cancer surveillance, and their abundance is linked to better prognosis in numerous tumor types. However, in uveal melanoma (UM), extensive immune infiltrate is associated with poor survival. This study aims to decipher the role of different tumor-infiltrating cell subsets in UM in order to identify potential targets for future immunotherapeutic treatment. We have chosen the TCGA-UVM cohort as a training dataset and GSE22138 as a testing dataset by mining publicly available databases. The abundance of 22 immune cell types was estimated using CIBERSORTx. Then, to determine the significance of tumor-infiltrating cell subsets in UM, we built a multicell type prognostic signature, which was validated in the testing cohort. The created signature was built upon the negative prognostic role of CD8+ T cells and M0 macrophages and the positive role of neutrophils. Based on the created signature score, we divided the patients into low- and high-risk groups. Kaplan-Meier, Cox, and ROC analyses demonstrated superior performance of our risk score compared to either clinical or pathologic characteristics of both cohorts. Further, we found the molecular pathways associated with cancer immunoevasion and metastasis to be enriched in the high-risk group, explaining both the lack of adequate immune surveillance despite increased infiltration of CD8+ T cells as well as the higher metastatic potential. Genes associated with tryptophan metabolism (IDO1 and KYNU) and metalloproteinases were among the most differentially expressed between the high- and low-risk groups. Our correlation analyses interpreted in context of published in vitro data strongly suggest the central role of CD8+ T cells in shifting the UM tumor microenvironment towards suppressive and metastasis-promoting. Therefore, we propose further investigations of IDO1 and metalloproteinases as novel targets for immunotherapy in lymphocyte-rich metastatic UM patients.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Integrated analysis of ceRNA network and tumor-infiltrating immune cells in esophageal cancer
    Chen, Yuhua
    Zhou, Hao
    Wang, Zhendong
    Huang, Zhanghao
    Wang, Jinjie
    Zheng, Miaosen
    Ni, Xuejun
    Liu, Lei
    BIOSCIENCE REPORTS, 2021, 41 (05)
  • [32] The Prognosis and Immune Prediction of Tumor-Infiltrating Immune Cells in Lung Cancer
    Liu, Xiangzheng
    Shang, Xueqian
    Li, Jian
    Zhang, Shijie
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [33] A comprehensive analysis of tumor-infiltrating immune cells in HPV-associated cancers
    Yang, H.
    Lin, A.
    Wei, K.
    Zhang, J.
    Luo, P.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S890 - S890
  • [34] The Prognostic Landscape of Tumor-Infiltrating Immune Cells and Immune Checkpoints in Glioblastoma
    Wu, Shiman
    Yang, Wenli
    Zhang, Hua
    Ren, Yan
    Fang, Ziwei
    Yuan, Chengjie
    Yao, Zhenwei
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2019, 18
  • [35] Level of tumor-infiltrating lymphocytes and density of infiltrating immune cells in different malignancies
    Castaneda, Carlos A.
    Castillo, Miluska
    Aliaga, Karina
    Bernabe, Luis A.
    Casavilca, Sandro
    Sanchez, Joselyn
    Torres-Cabala, Carlos A.
    Gomez, Henry L.
    Mas, Luis
    Dunstan, Jorge
    Cotrina, Jose M.
    Abugattas, Julio
    Chavez, Ivan
    Ruiz, Eloy
    Montenegro, Paola
    Rojas, Victor
    Orrego, Enrique
    Galvez-Nino, Marco
    Felix, Brayam
    Landa-Baella, Maria P.
    Vidaurre, Tatiana
    Villa, Maria R.
    Zevallos, Rocio
    Taxa, Luis
    Guerra, Henry
    BIOMARKERS IN MEDICINE, 2019, 13 (17) : 1481 - 1491
  • [36] Addressing the importance of melanoma tumor-infiltrating lymphocytes in disease progression and clinicopathological characteristics
    Zablocka, Tatjana
    Nikolajeva, Anna
    Kreismane, Madara
    Pjanova, Dace
    Isajevs, Sergejs
    MOLECULAR AND CLINICAL ONCOLOGY, 2021, 15 (06)
  • [37] Different Subsets of Tumor-Infiltrating Lymphocytes Correlate with Macrophage Influx and Monosomy 3 in Uveal Melanoma
    Bronkhorst, Inge H. G.
    Vu, T. H. Khanh
    Jordanova, Ekaterina S.
    Luyten, Gregorius P. M.
    van der Burg, Sjoerd H.
    Jager, Martine J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2012, 53 (09) : 5370 - 5378
  • [38] Analysis of tumor-infiltrating T cells made easy - Complete workflows improve the isolation and analysis of tumor-infiltrating T cells
    Evaristo, C.
    Siemer, R.
    Agorku, D.
    Brauner, J.
    Hardt, O.
    Dose, C.
    Richter, A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2017, 47 : 300 - 300
  • [39] Tumor immunity: A brief overview of tumor-infiltrating immune cells and research advances into tumor-infiltrating lymphocytes in gynecological malignancies (Review)
    Wang, Zi-Tao
    Deng, Zhi-Min
    Dai, Fang-Fang
    Yuan, Meng-Qin
    Liu, Shi-Yi
    Li, Bing-Shu
    Cheng, Yan-Xiang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2024, 27 (04)
  • [40] Significance of Tumor-Infiltrating Immune Cells in the Prognosis of Colon Cancer
    Wu, Dejun
    Ding, Yue
    Wang, Tingfeng
    Cui, Peng
    Huang, Liangliang
    Min, Zhijun
    Xu, Ming
    ONCOTARGETS AND THERAPY, 2020, 13 : 4581 - 4589